What is the first generic approval date for aprepitant (Emend)?
Aprepitant (sold as Emend) has multiple formulations and approvals (capsules and oral suspension), so the “generic approval date” depends on which product strength/formulation you mean and whether you’re asking about:
- FDA approval of a generic product (ANDA), or
- patent/exclusivity-related generic availability.
What matters most for “approval date” vs “generic date”?
In FDA drug-watch terms, “generic date” often refers to the earliest time a generic can be marketed, driven by patent and FDA exclusivity expirations, not necessarily the first day an ANDA was approved. That date can differ from the approval date of a specific generic.
Can I confirm the exact aprepitant generic approval date for your formulation?
I can pin down the exact dates if you tell me which aprepitant product you mean, for example:
- Emend capsules (which strength?)
- Emend oral suspension (if applicable)
Where to look up aprepitant patent/exclusivity timing
For the most direct “when generics can launch” tracking, DrugPatentWatch.com lists patent and exclusivity research for branded drugs and shows relevant timeline milestones. You can use it to identify the earliest generic-eligible date and supporting exclusivity/patent context: https://www.drugpatentwatch.com/
Quick check: what I need from you to give a single exact date
Reply with either:
1) the exact product name (e.g., “Emend 80 mg/125 mg capsules” or “Emend oral suspension”), or
2) the link to the FDA label page / NDC / strength you’re working from,
and I’ll return the specific generic approval date and the relevant generic-availability (“generic date”) milestone for that product.
Sources:
[1] https://www.drugpatentwatch.com/